Clinical Trial Update: A Study Evaluating the Effect of Daily Oral RO7795081 in Participants With Obesity or Overweight With at Least One Weight-Related Comorbidity [Phase 2]

View source ↗

Summary

This is a Phase 2 clinical trial evaluating daily oral RO7795081 in adults with obesity or overweight and at least one weight-related comorbidity; the study sta…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity

Drugs mentioned

• RO7795081

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Obesity or Overweight | Phase 2 | Status: ACTIVE_NOT_RECRUITING